Ryan Walsh, Senior Vice President, Client Services
With over 20 years of pharmaceutical and trade industry experience, Ryan’s expertise covers a wide variety of areas, with a particular focus on market access strategy, pricing and contracting. At RE, Ryan is responsible for marketing and promotional activities, product, and service quality and, most importantly, client development and support.
Ryan joins Real Endpoints from Novartis where he was a leader in the market access organization with responsibility for access strategy development and execution for the immunology portfolio.
Prior to Novartis, Ryan served as an executive at Walgreens, where he led the development and implementation of a portfolio of innovative, multichannel solutions to provide value to global biopharmaceutical manufacturers in the areas of commercial strategy and patient acquisition and retention.
He’d gone to Walgreens from Merck, where he led various US and Global Market Access groups, and Schering-Plough, where he started his career, and worked in a variety of roles, including market access, sales, and learning and development.